Mettler-Toledo International Inc
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laborat… Read more
Mettler-Toledo International Inc (MTD) - Net Assets
Latest net assets as of September 2025: $-249.20 Million USD
Based on the latest financial reports, Mettler-Toledo International Inc (MTD) has net assets worth $-249.20 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.52 Billion) and total liabilities ($3.77 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-249.20 Million |
| % of Total Assets | -7.08% |
| Annual Growth Rate | N/A |
| 5-Year Change | -144.89% |
| 10-Year Change | -121.86% |
| Growth Volatility | 144.41 |
Mettler-Toledo International Inc - Net Assets Trend (1997–2024)
This chart illustrates how Mettler-Toledo International Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Mettler-Toledo International Inc (1997–2024)
The table below shows the annual net assets of Mettler-Toledo International Inc from 1997 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-126.89 Million | +15.37% |
| 2023-12-31 | $-149.94 Million | -704.76% |
| 2022-12-31 | $24.79 Million | -85.54% |
| 2021-12-31 | $171.42 Million | -39.36% |
| 2020-12-31 | $282.68 Million | -32.82% |
| 2019-12-31 | $420.78 Million | -28.69% |
| 2018-12-31 | $590.06 Million | +7.82% |
| 2017-12-31 | $547.28 Million | +25.83% |
| 2016-12-31 | $434.94 Million | -25.07% |
| 2015-12-31 | $580.46 Million | -19.34% |
| 2014-12-31 | $719.60 Million | -23.04% |
| 2013-12-31 | $935.05 Million | +13.04% |
| 2012-12-31 | $827.22 Million | +5.90% |
| 2011-12-31 | $781.14 Million | +1.24% |
| 2010-12-31 | $771.58 Million | +8.50% |
| 2009-12-31 | $711.14 Million | +41.31% |
| 2008-12-31 | $503.25 Million | -13.43% |
| 2007-12-31 | $581.29 Million | -7.86% |
| 2006-12-31 | $630.86 Million | -4.27% |
| 2005-12-31 | $659.00 Million | -8.58% |
| 2004-12-31 | $720.89 Million | +10.23% |
| 2003-12-31 | $654.00 Million | +30.18% |
| 2002-12-31 | $502.39 Million | +29.42% |
| 2001-12-31 | $388.18 Million | +117.06% |
| 2000-12-31 | $178.84 Million | +59.68% |
| 1999-12-31 | $112.00 Million | +93.10% |
| 1998-12-31 | $58.00 Million | +100.69% |
| 1997-12-31 | $28.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mettler-Toledo International Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 859562000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $8.37 Billion | % |
| Common Stock | $448.00K | % |
| Other Comprehensive Income | $-345.86 Million | % |
| Total Equity | $-126.89 Million | 100.00% |
Mettler-Toledo International Inc Competitors by Market Cap
The table below lists competitors of Mettler-Toledo International Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Elite Material Co Ltd
TW:2383
|
$24.52 Billion |
|
Chocoladefabriken Lindt & Sprüngli AG
PINK:COCXF
|
$24.55 Billion |
|
Cabot Oil & Gas Corp.
LSE:0HRZ
|
$24.62 Billion |
|
Caseys General Stores Inc
NASDAQ:CASY
|
$24.63 Billion |
|
China Pacific Insurance (Group) Co. Ltd
F:75C
|
$24.50 Billion |
|
Jabil Circuit Inc
NYSE:JBL
|
$24.48 Billion |
|
United Microelectronics
NYSE:UMC
|
$24.46 Billion |
|
Canon Inc.
PINK:CAJPY
|
$24.42 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mettler-Toledo International Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -149,938,000 to -126,890,000, a change of 23,048,000.
- Net income of 863,140,000 contributed positively to equity growth.
- Share repurchases of 849,997,000 reduced equity.
- Other comprehensive income decreased equity by 26,043,000.
- Other factors increased equity by 35,948,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $863.14 Million | +680.23% |
| Share Repurchases | $850.00 Million | -669.87% |
| Other Comprehensive Income | $-26.04 Million | -20.52% |
| Other Changes | $35.95 Million | +28.33% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Mettler-Toledo International Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-12-31 | $0.80 | $1206.72 | x |
| 1998-12-31 | $1.32 | $1206.72 | x |
| 1999-12-31 | $2.71 | $1206.72 | x |
| 2000-12-31 | $4.24 | $1206.72 | x |
| 2001-12-31 | $9.03 | $1206.72 | x |
| 2002-12-31 | $11.07 | $1206.72 | x |
| 2003-12-31 | $14.37 | $1206.72 | x |
| 2004-12-31 | $15.85 | $1206.72 | x |
| 2005-12-31 | $15.22 | $1206.72 | x |
| 2006-12-31 | $15.47 | $1206.72 | x |
| 2007-12-31 | $15.32 | $1206.72 | x |
| 2008-12-31 | $14.36 | $1206.72 | x |
| 2009-12-31 | $20.74 | $1206.72 | x |
| 2010-12-31 | $22.60 | $1206.72 | x |
| 2011-12-31 | $23.79 | $1206.72 | x |
| 2012-12-31 | $25.99 | $1206.72 | x |
| 2013-12-31 | $30.43 | $1206.72 | x |
| 2014-12-31 | $24.33 | $1206.72 | x |
| 2015-12-31 | $20.53 | $1206.72 | x |
| 2016-12-31 | $16.09 | $1206.72 | x |
| 2017-12-31 | $20.74 | $1206.72 | x |
| 2018-12-31 | $22.89 | $1206.72 | x |
| 2019-12-31 | $16.85 | $1206.72 | x |
| 2020-12-31 | $11.68 | $1206.72 | x |
| 2021-12-31 | $7.31 | $1206.72 | x |
| 2022-12-31 | $1.09 | $1206.72 | x |
| 2023-12-31 | $-6.82 | $1206.72 | x |
| 2024-12-31 | $-5.95 | $1206.72 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mettler-Toledo International Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 22.29%
- • Asset Turnover: 1.20x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (174.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | -259.45% | -7.50% | 1.17x | 29.50x | $-68.44 Million |
| 1998 | 69.89% | 4.02% | 1.14x | 15.25x | $32.22 Million |
| 1999 | 42.95% | 4.51% | 1.30x | 7.33x | $36.90 Million |
| 2000 | 39.21% | 6.40% | 1.23x | 4.96x | $52.23 Million |
| 2001 | 18.62% | 6.29% | 0.97x | 3.06x | $33.45 Million |
| 2002 | 19.99% | 8.27% | 0.93x | 2.59x | $50.18 Million |
| 2003 | 14.65% | 7.35% | 0.94x | 2.12x | $30.44 Million |
| 2004 | 14.98% | 7.69% | 0.95x | 2.05x | $35.87 Million |
| 2005 | 16.53% | 7.35% | 0.89x | 2.53x | $43.00 Million |
| 2006 | 24.97% | 9.88% | 1.00x | 2.52x | $94.45 Million |
| 2007 | 30.71% | 9.95% | 1.07x | 2.89x | $120.38 Million |
| 2008 | 40.29% | 10.28% | 1.19x | 3.31x | $152.45 Million |
| 2009 | 24.27% | 9.98% | 1.01x | 2.42x | $101.48 Million |
| 2010 | 30.09% | 11.80% | 0.86x | 2.96x | $154.99 Million |
| 2011 | 34.50% | 11.67% | 1.05x | 2.82x | $191.38 Million |
| 2012 | 35.16% | 12.42% | 1.16x | 2.44x | $208.13 Million |
| 2013 | 32.74% | 12.87% | 1.11x | 2.30x | $212.59 Million |
| 2014 | 47.00% | 13.61% | 1.24x | 2.79x | $266.28 Million |
| 2015 | 60.78% | 14.73% | 1.22x | 3.38x | $294.77 Million |
| 2016 | 88.37% | 15.32% | 1.16x | 4.98x | $340.88 Million |
| 2017 | 68.70% | 13.80% | 1.07x | 4.66x | $321.24 Million |
| 2018 | 86.87% | 17.46% | 1.12x | 4.44x | $453.60 Million |
| 2019 | 133.35% | 18.65% | 1.08x | 6.63x | $519.03 Million |
| 2020 | 213.23% | 19.54% | 1.10x | 9.96x | $574.47 Million |
| 2021 | 448.59% | 20.68% | 1.12x | 19.41x | $751.84 Million |
| 2022 | 3519.15% | 22.26% | 1.12x | 140.86x | $870.02 Million |
| 2023 | 0.00% | 20.82% | 1.13x | 0.00x | $803.77 Million |
| 2024 | 0.00% | 22.29% | 1.20x | 0.00x | $875.83 Million |
Industry Comparison
This section compares Mettler-Toledo International Inc's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mettler-Toledo International Inc (MTD) | $-249.20 Million | -259.45% | N/A | $24.52 Billion |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |